• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

根据美国国家胆固醇教育计划制定的针对儿童和青少年的可酌情使用的筛查指标的定义及应用。

Definition and application of the discretionary screening indicators according to the National Cholesterol Education Program for Children and Adolescents.

作者信息

Diller P M, Huster G A, Leach A D, Laskarzewski P M, Sprecher D L

机构信息

Department of Family Medicine, University of Cincinnati, Ohio 45267-0540.

出版信息

J Pediatr. 1995 Mar;126(3):345-52. doi: 10.1016/s0022-3476(95)70446-9.

DOI:10.1016/s0022-3476(95)70446-9
PMID:7869190
Abstract

OBJECTIVES

(1) To propose definitions for the discretionary screening indicators described by the National Cholesterol Education Program for Children and Adolescents (NCEP-Peds); (2) to examine the relative prevalence of major screening indicators (family history of premature heart disease and parental plasma cholesterol concentration > or = 6.21 mmol/L (240 mg/dl)) and discretionary screening indicators (excessive consumption of fat or cholesterol or both, smoking, diabetes, hypertension, and steroid use) in a family population; and (3) to evaluate the relative value of the major and the discretionary indicators in detecting high serum levels of low-density lipoprotein-cholesterol (LDL-C) (> or = 3.36 mmol/L (> or = 130 mg/dl)).

DESIGN

Control cohort from a case-control study.

SETTING

Lipid research clinic.

PARTICIPANTS

White children and adolescents < 20 years of age from 232 nuclear families who participated in the Cincinnati Myocardial Infarction Hormone Study.

MAIN OUTCOME MEASURES

(1) Number of children who have major and discretionary screening indicators; (2) sensitivity and specificity of the major and the discretionary screening indicators in identifying children with LDL-C concentrations > 3.36 mmol/L (130 mg/dl) (high LDL-C).

RESULTS

With cutoff points of the 90th percentile for blood pressure, the 85th percentile for obesity, and the 80th percentile for dietary fat and cholesterol, and self-report for diabetes, smoking, and corticosteroid use, 54% of the 232 children in the cohort had one or more discretionary indicators. Additionally, applying the major screening indicators raised the percentage of children identified to 74%. Twenty-eight percent had both major and discretionary indicators. Having a discretionary screening indicator did not increase the probability of having a major indicator. Applying both discretionary and major screening indicators to the cohort identified 96% of the children who had a high concentration of LDL-C; 30% of the children with high LDL-C levels were discovered solely by the discretionary indicators. Similar sensitivity and specificity were noted between the major and the discretionary indicators. Children with high LDL-C concentrations were more likely to have multiple screening indicators.

CONCLUSION

Discretionary and major screening indicators suggested by the National Cholesterol Education Program for Children and Adolescents identify different subsets of children at risk of having premature cardiovascular disease. Both major and discretionary indicators contribute to the identification of children with high LDL-C concentrations.

摘要

目的

(1)为美国国家胆固醇教育计划儿童及青少年版(NCEP - Peds)中描述的可自由选择的筛查指标提出定义;(2)在一个家庭群体中,检查主要筛查指标(早发性心脏病家族史以及父母血浆胆固醇浓度≥6.21 mmol/L(240 mg/dl))和可自由选择的筛查指标(脂肪或胆固醇或两者过度摄入、吸烟、糖尿病、高血压以及使用类固醇)的相对流行情况;(3)评估主要指标和可自由选择指标在检测低密度脂蛋白胆固醇(LDL - C)血清水平升高(≥3.36 mmol/L(≥130 mg/dl))方面的相对价值。

设计

病例对照研究中的对照队列。

设置

脂质研究诊所。

参与者

来自232个核心家庭的20岁以下白人儿童及青少年,他们参与了辛辛那提心肌梗死激素研究。

主要观察指标

(1)具有主要和可自由选择筛查指标的儿童数量;(2)主要和可自由选择筛查指标在识别LDL - C浓度>3.36 mmol/L(130 mg/dl)(高LDL - C)儿童方面的敏感性和特异性。

结果

以血压第90百分位数、肥胖第85百分位数、饮食脂肪和胆固醇第80百分位数为界值,以及糖尿病、吸烟和使用皮质类固醇的自我报告为依据,该队列中232名儿童中有54%有一项或多项可自由选择的指标。此外,应用主要筛查指标使被识别出的儿童比例提高到74%。28%的儿童同时具有主要和可自由选择的指标。具有可自由选择的筛查指标并不会增加具有主要指标的可能性。将可自由选择和主要筛查指标应用于该队列,识别出了96%的LDL - C浓度高的儿童;30%的LDL - C水平高的儿童仅通过可自由选择的指标被发现。主要指标和可自由选择指标之间的敏感性和特异性相似。LDL - C浓度高的儿童更有可能有多个筛查指标。

结论

美国国家胆固醇教育计划儿童及青少年版提出的可自由选择和主要筛查指标识别出了有过早发生心血管疾病风险的不同儿童亚组。主要指标和可自由选择指标都有助于识别LDL - C浓度高的儿童。

相似文献

1
Definition and application of the discretionary screening indicators according to the National Cholesterol Education Program for Children and Adolescents.根据美国国家胆固醇教育计划制定的针对儿童和青少年的可酌情使用的筛查指标的定义及应用。
J Pediatr. 1995 Mar;126(3):345-52. doi: 10.1016/s0022-3476(95)70446-9.
2
3
Challenges to implementing the current pediatric cholesterol screening guidelines into practice.将当前儿科胆固醇筛查指南应用于实践所面临的挑战。
Pediatrics. 1994 Sep;94(3):296-302.
4
5
Low high-density lipoprotein cholesterol and other coronary heart disease risk factors in patients with total cholesterol levels greater than 5.17 mmol/L (200 mg/dL) in family practice. A report from CEN.基层医疗中总胆固醇水平大于5.17 mmol/L(200 mg/dL)患者的低高密度脂蛋白胆固醇及其他冠心病危险因素。CEN的一份报告
J Am Board Fam Pract. 1991 Sep-Oct;4(5):285-97.
6
Evaluation of AAP guidelines for cholesterol screening in youth: Project HeartBeat!青少年胆固醇筛查的美国儿科学会指南评估:心跳计划!
Am J Prev Med. 2009 Jul;37(1 Suppl):S71-7. doi: 10.1016/j.amepre.2009.04.008.
7
Usefulness of the American Academy of Pediatrics recommendations for identifying youths with hypercholesterolemia.
Pediatrics. 2004 Jun;113(6):1723-7. doi: 10.1542/peds.113.6.1723.
8
Influence of cholesterol screening and nutritional counseling in reducing cholesterol levels in children. The American Heart Association.
Clin Pediatr (Phila). 1997 May;36(5):267-72. doi: 10.1177/000992289703600503.
9
Family history evaluation as a predictive screen for childhood hypercholesterolemia. Pediatric Practice Research Group.家族史评估作为儿童高胆固醇血症的预测性筛查。儿科实践研究组。
Pediatrics. 1989 Aug;84(2):365-73.
10
Failure of current guidelines for cholesterol screening in urban African-American adolescents.
Pediatrics. 1996 Sep;98(3 Pt 1):383-8.

引用本文的文献

1
A systematic review and meta-analysis on screening lipid disorders in the pediatric age group.关于儿科年龄组脂质紊乱筛查的系统评价和荟萃分析。
J Res Med Sci. 2015 Dec;20(12):1191-9. doi: 10.4103/1735-1995.172989.
2
Glycolipid metabolic status of overweight/obese adolescents aged 9- to 15-year-old and the BMI-SDS/BMI cut-off value of predicting dyslipidemiain boys, Shanghai, China: a cross-sectional study.中国上海:一项横断面研究显示,9-15 岁超重/肥胖青少年的糖脂代谢状况,以及 BMI-SDS/BMI 切点值对男童血脂异常的预测价值。
Lipids Health Dis. 2013 Aug 28;12:129. doi: 10.1186/1476-511X-12-129.
3
Reduction of risk for cardiovascular disease in children and adolescents.
降低儿童和青少年患心血管疾病的风险。
Circulation. 2011 Oct 11;124(15):1673-86. doi: 10.1161/CIRCULATIONAHA.110.016170.
4
Evaluation of AAP guidelines for cholesterol screening in youth: Project HeartBeat!青少年胆固醇筛查的美国儿科学会指南评估:心跳计划!
Am J Prev Med. 2009 Jul;37(1 Suppl):S71-7. doi: 10.1016/j.amepre.2009.04.008.
5
High prevalence of cardiovascular risk factors in children and adolescents with type 1 diabetes: a population-based study.1型糖尿病儿童和青少年中心血管危险因素的高患病率:一项基于人群的研究。
Diabetologia. 2008 Apr;51(4):554-61. doi: 10.1007/s00125-007-0921-8. Epub 2008 Jan 15.
6
Hereditary dyslipidemias and combined risk factors in children with a family history of premature coronary artery disease.有早发冠心病家族史儿童的遗传性血脂异常及合并危险因素
Arch Dis Child. 2000 Apr;82(4):292-6. doi: 10.1136/adc.82.4.292.
7
A rational approach to treating hypercholesterolaemia in children. Weighing the risks and benefits.治疗儿童高胆固醇血症的合理方法。权衡风险与益处。
Drug Saf. 1997 May;16(5):330-41. doi: 10.2165/00002018-199716050-00004.